These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29212288)

  • 1. Failure of ocular photodynamic therapy for secondary choroidal metastasis: a case report and literature review.
    Hua R; Li W; Wu W; Tao J; Peng Q
    Oncotarget; 2017 Nov; 8(55):95030-95035. PubMed ID: 29212288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subfoveal retinal and choroidal thickness after verteporfin photodynamic therapy for polypoidal choroidal vasculopathy.
    Maruko I; Iida T; Sugano Y; Saito M; Sekiryu T
    Am J Ophthalmol; 2011 Apr; 151(4):594-603.e1. PubMed ID: 21295766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of morphologic alterations by spectral-domain optical coherence tomography before and after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy.
    Shinojima A; Kawamura A; Mori R; Fujita K; Yuzawa M
    Retina; 2011 Oct; 31(9):1912-20. PubMed ID: 21952105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy.
    Maruko I; Iida T; Sugano Y; Ojima A; Ogasawara M; Spaide RF
    Ophthalmology; 2010 Sep; 117(9):1792-9. PubMed ID: 20472289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy with verteporfin of choroidal malignancy from breast cancer.
    Isola V; Pece A; Pierro L
    Am J Ophthalmol; 2006 Nov; 142(5):885-7. PubMed ID: 17056382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced-fluence photodynamic therapy for subfoveal serous pigment epithelial detachment with choroidal vascular hyperpermeability.
    Goto S; Gomi F; Ueno C; Nishida K
    Am J Ophthalmol; 2012 Nov; 154(5):865-871.e1. PubMed ID: 22840480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choroidal thickness following extrafoveal photodynamic treatment with verteporfin in patients with central serous chorioretinopathy.
    Pryds A; Larsen M
    Acta Ophthalmol; 2012 Dec; 90(8):738-43. PubMed ID: 21586096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choroidal neovascularization following photodynamic therapy in a patient with chronic central serous chorioretinopathy.
    Yaman A; Arikan G; Saatci AO; Cingil G
    Bull Soc Belge Ophtalmol; 2007; (303):69-73. PubMed ID: 17894291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy.
    Maruko I; Iida T; Sugano Y; Furuta M; Sekiryu T
    Retina; 2011 Oct; 31(9):1921-7. PubMed ID: 21878850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PHOTODYNAMIC THERAPY FOR CHOROIDAL NEVUS WITH SUBFOVEAL FLUID.
    Pointdujour-Lim R; Mashayekhi A; Shields JA; Shields CL
    Retina; 2017 Apr; 37(4):718-723. PubMed ID: 27433882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectral domain optical coherence tomography and angiographic findings in multifocal posterior pigment epitheliopathy treated with low-fluence photodynamic therapy.
    Kuroyanagi K; Sakai T; Kasai K; Tsuneoka H
    Clin Exp Optom; 2013 Jan; 96(1):126-9. PubMed ID: 22784102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Half-fluence photodynamic therapy in chronic central serous chorioretinopathy.
    Smretschnig E; Ansari-Shahrezaei S; Hagen S; Glittenberg C; Krebs I; Binder S
    Retina; 2013 Feb; 33(2):316-23. PubMed ID: 23314238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal ranibizumab therapy versus photodynamic therapy for idiopathic choroidal neovascularization: a comparative study on visual acuity, retinal and choroidal thickness.
    Shi X; Wei W; Zhang C
    Chin Med J (Engl); 2014; 127(12):2279-85. PubMed ID: 24931242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy for polypoidal choroidal vasculopathy.
    Nowak-Sliwinska P; van den Bergh H; Sickenberg M; Koh AH
    Prog Retin Eye Res; 2013 Nov; 37():182-99. PubMed ID: 24140257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodal Imaging and Choroidal Volumetric Changes After Half-fluence PDT in Central Serous Chorioretinopathy.
    Munk MR; Shah R; Pappas F; Baddar D; Wong B; Jampol LM; Fawzi AA
    Curr Eye Res; 2016; 41(1):97-106. PubMed ID: 25612245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy of choroidal hemangioma in sturge-weber syndrome, with a review of treatments for diffuse and circumscribed choroidal hemangiomas.
    Tsipursky MS; Golchet PR; Jampol LM
    Surv Ophthalmol; 2011; 56(1):68-85. PubMed ID: 21074819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optical coherence tomography characteristics of choroidal metastasis.
    Arevalo JF; Fernandez CF; Garcia RA
    Ophthalmology; 2005 Sep; 112(9):1612-9. PubMed ID: 16039718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Photodynamic therapy for treatment of chronic or recurrent central serous chorioretinopathy].
    Li L; Yuan F; Xu GZ; Wang WJ
    Zhonghua Yan Ke Za Zhi; 2012 Feb; 48(2):106-13. PubMed ID: 22490944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the effects of photodynamic therapy on chronic central serous chorioretinopathy based on the mean choroidal thickness and the lumen area of abnormal choroidal vessels.
    Hua R; Liu L; Li C; Chen L
    Photodiagnosis Photodyn Ther; 2014 Dec; 11(4):519-25. PubMed ID: 25102163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathophysiology of macular diseases--morphology and function].
    Iida T
    Nippon Ganka Gakkai Zasshi; 2011 Mar; 115(3):238-74; discussion 275. PubMed ID: 21476310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.